1 Min Read
Nov 1 (Reuters) - Ra Pharmaceuticals Inc
* Ra Pharmaceuticals Inc files for mixed shelf offering of up to $250 million - SEC filing Source text: (bit.ly/2A6uuro) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.